This topic contains a solution. Click here to go to the answer

Author Question: What are the common grounds for challenging prospective jury members for cause? What will be an ... (Read 33 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
What are the common grounds for challenging prospective jury members for cause?
 
  What will be an ideal response?

Question 2

Explain the ambiguity of a jury of ones peers.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

b614102004

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

Answer:  Bias
 Preconceived notions about the defendants guilt
 Opposition to the death penalty

Answer to Question 2

Answer: The phrase originated with the Magna Carta in England to distinguish noblemen from commoners.
Modernly, it has been defined as a jury of ones equals. Further, some state that the phrase means a jury
made up of a cross-section of the community. Keep in mind that the word peers does not appear in the
Constitution.




JGIBBSON

  • Member
  • Posts: 538
Reply 2 on: Aug 17, 2018
Gracias!


momolu

  • Member
  • Posts: 320
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library